Nectar Lifesciences Ltd.

View in App
28.98 -0.13 ▼-0.5%

11 December 2023, 04:01:00 PM
Volume: 62,665

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.neclife.com
Market Cap 648.79 Cr.
Enterprise Value(EV) 1,331.18 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.12 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.33 Trailing Twelve Months Ending 2023-09
Book Value / Share 47.60 Trailing Twelve Months Ending 2023-09
Price to Book Value 0.61 Calculated using Price: 28.93
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 22.43 Cr. 224,260,970 Shares
FaceValue 1
About Nectar Lifesciences Ltd.
Nectar Lifesciences (NecLife) incorporated in 1995, is a $200 million pharmaceutical organization. The company offers a range of Cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms. The company was previously known as Surya Medicare and is is promoted by Sanjiv Goyal.

Nectar Lifesciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Nectar Lifesciences Ltd. Performance

View details >>
1 Day
-0.45%
1 Week
-2.03%
1 Month
+18.04%
3 Month
+6.82%
6 Month
+63.18%
1 Year
+29.09%
2 Year
+15.92%
5 Year
+47.86%
10 Year
+76.17%

Nectar Lifesciences Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.17 5.78 5.64 5.06 4.40 2.84 -6.67 2.33 -2.25
Return on Capital Employed (%) 11.58 9.95 9.73 9.13 10.29 8.32 1.41 5.77 1.97
Return on Assets (%) 2.70 2.14 2.15 1.97 1.75 1.19 -2.93 1.05 -1.06

Nectar Lifesciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 958 954 1,007 1,059 1,105 1,136 1,062 1,088 1,065 1,067
Non Curr. Liab. 397 362 296 356 300 249 126 296 213 172
Curr. Liab. 1,156 1,240 1,279 1,309 1,300 1,248 1,187 1,004 891 885
Minority Int.
Equity & Liab. 2,510 2,556 2,581 2,724 2,705 2,633 2,376 2,388 2,169 2,124
Non Curr. Assets 1,106 1,092 1,085 1,063 1,036 1,018 1,137 1,033 937 916
Curr. Assets 1,369 1,464 1,496 1,661 1,669 1,615 1,239 1,355 1,231 1,208
Misc. Exp. not W/O 36
Total Assets 2,510 2,556 2,581 2,724 2,705 2,633 2,376 2,388 2,169 2,124

Nectar Lifesciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 1,644 1,676 1,644 1,876 2,783 2,366 1,543 1,669 1,524 1,525
Other Income 20 6 23 6 6 4 11 11 43 42
Total Income 1,664 1,681 1,666 1,882 2,789 2,371 1,555 1,680 1,567 1,567
Total Expenditure -1,377 -1,437 -1,419 -1,640 -2,519 -2,147 -1,442 -1,510 -1,471 -1,443
PBIDT 287 245 247 242 270 224 113 170 96 124
Interest -126 -123 -117 -115 -148 -126 -112 -79 -79 -75
Depreciation -77 -57 -62 -64 -63 -61 -60 -57 -59 -60
Taxation -18 -10 -12 -10 -11 -6 12 -9 18 9
Exceptional Items -25
PAT 66 54 55 52 48 32 -73 25 -24 -3
Minority Interest
Share Associate
Other Related Items 1
Consolidated Net Profit 66 54 55 52 48 32 -73 25 -24 -3
Adjusted EPS 3 2 2 2 2 1 -3 1 -1 0

Nectar Lifesciences Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 255 144 169 199 65 239 285 21 95 134
Cash Fr. Inv. -90 -60 -77 -18 -29 -26 -33 -29 17 52
Cash Fr. Finan. -161 -61 -89 -204 -40 -201 -252 11 -119 -186
Net Change 4 23 3 -23 -4 12 0 4 -8 0
Cash & Cash Eqvt 10 33 37 13 9 21 21 26 18 18

Nectar Lifesciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80
Public 44.20 44.20 44.20 44.20 44.20 44.20 44.20 44.20 44.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Nectar Lifesciences Ltd. Announcements

View details >>
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the copy of newspapers for publication of financial results for the period ended on 30.09.2023
Fri, 10 Nov 2023
Unaudited Financial Results For The Period Ended On 30.09.2023
Please find attached herewith Unaudited Financial Results for the period ended on September 30 2023.
Fri, 03 Nov 2023
Board Meeting Intimation for Board Meeting Intimation For Financial Results For The Quarter And Half Year Ended On September 30 2023 And Other Business Matters.
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the financial Results for the quarter and half year ended on September 30 2023 and other business matters.

Nectar Lifesciences Ltd. Technical Scans

View details >>
Mon, 11 Dec 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
MFI Bearish MFI Bearish

Nectar Lifesciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,485.82 1,235.70 +0.0%
Divi's Laboratories Ltd. 97,380.51 3,668.25 -0.4%
Cipla Ltd. 97,091.96 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. 91,293.11 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. 79,724.28 5,544.70 -0.1%
Mankind Pharma Ltd. 76,862.91 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. 70,227.43 2,075.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 73.12 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 28.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 17.93 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.30 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 59.96 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.64 2,075.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-09 7.68 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-09 3.91 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.58 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.12 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.47 2,075.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,075.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,075.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.70 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,668.25 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.60 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,472.90 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,544.70 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,918.75 -1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,075.00 +1.0%

Nectar Lifesciences Ltd. FAQ's

What is Nectar Lifesciences share price?
Can I buy Nectar Lifesciences shares now?
What is the Market Cap of Nectar Lifesciences?
What are the key metrics to analyse Nectar Lifesciences?
What is the 52 Week High and Low of Nectar Lifesciences?
What is the trend of Nectar Lifesciences share price?